	Vertriebs- Und Verwaltungskosten		Datum
Abbott	USD 3.13B	125M	2025-12
Agenus	USD 23.6M	448K	2025-09
Agios Pharmaceuticals	USD 41.27M	4.6M	2025-09
Anika Therapeutics	USD 12.91M	17.8M	2025-03
Arrowhead Research	USD 46.02M	8.84M	2025-12
Enanta Pharmaceuticals	USD -1.05	0.31	2024-12
Halozyme Therapeutics	USD 37.53M	4.53M	2025-09
Heron Therapeutics	USD 23.34M	4.18M	2024-09
Insmed	USD 186.38M	109.94M	2025-09
Integra LifeSciences	USD 169.05M	10.84M	2025-09
Intrexon	USD 10.31M	41K	2024-06
J&J	USD 6.75B	831M	2025-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Ligand Pharmaceuticals	USD 28.45M	8.27M	2025-09
MacroGenics	USD 9.9M	600K	2025-09
Merit Medical Systems	USD 107.38M	5.72M	2025-09
Rigel Pharmaceuticals	USD 27.04M	1M	2024-09
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sanofi	EUR 2.75B	455M	2025-12
Smith & Nephew	USD 1.42B	65M	2025-12
Stryker	USD 2.14B	150M	2025-12
Surmodics	USD 14.58M	2.05M	2024-09
Veracyte	USD 51.73M	5.91M	2025-09
Xencor	USD 87.78M	72.66M	2025-09
Zimmer Biomet Holdings	USD 855.7M	44.3M	2025-12

Anika Therapeutics Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.